Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dembinski, J
Right arrow Articles by Bartmann, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dembinski, J
Right arrow Articles by Bartmann, P
Arch Dis Child Fetal Neonatal Ed 2000;82:F215-F217 ( May )

Thyroid function in very low birthweight infants after intravenous administration of the iodinated contrast medium iopromide

J Dembinskia, V Arpeb, M Krollb, G Hieronimib, P Bartmanna

a Department of Neonatology, Children's University Clinic Bonn, Germany, b Department of Neonatology, Children's Clinic, Olgahospital, Stuttgart, Germany

Correspondence to: Dr Dembinski, Department of Neonatology, Center of Pediatrics, University of Bonn, Adenauerallee119, 53113 Bonn, Germany

Accepted 24 November 1999

BACKGROUND---Thyroid function disorders have often been observed in preterm infants after intravenous administration of iodinated contrast medium. The effect on thyroid function depends on the dosage, but the choice of the contrast medium may be equally important, as there are appreciable pharmacological differences between them.
METHOD---Thyroid function was analysed in 20 very low birthweight infants of gestational age less than 30 weeks after injection of iopromide, a monomeric non-ionic iodinated contrast medium. Levels of free thyroxine and thyroid stimulating hormone were compared with those in 26 control infants.
RESULTS---Free thyroxine levels in all study infants ranged from 9.0 to 25.7 pmol/l (days 14-21) and 9.0 to 23.2 pmol/l (days 35-49), and thyroid stimulating hormone levels ranged from 0.13 to 0.26 mU/l (days 14-21) and 0.26 to 11.11 mU/l (days 35-49). These levels were not altered after injection of iopromide.
CONCLUSION---The risk of transient hypothyroidism or hyperthyrotropinaemia may be reduced with the use of iopromide compared with other contrast media.


Keywords: preterm infants; iodine; iopromide; thyroid function; thyroxine; contrast medium


© 2000 by Archives of Disease in Childhood






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2000 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health